Maria Eugenia O. G.
- Country
- Spain
- Department
- Servicio de Oncologia
Research Overview
- Phase I/Ib Clinical Evaluation of PM54 in Patients with Advanced Solid Tumors
- Phase I Study of ZL-1310 Pharmacokinetics and Tolerability in Patients with Small Cell Lung Cancer
- Evaluation of BI 764532 in Combination with Standard of Care for Tolerability in Patients with Extensive-Stage Small Cell Lung Carcinoma
Data & Insights
Has run more than one trial at 201 of 374 partner sites.
Specializations
Oncology Specialization
The investigator specializes in the treatment of extensive-stage small cell lung cancer (ES-SCLC), focusing on innovative therapeutic approaches for this aggressive form of lung cancer.
- Advanced Lung Cancer Management
- Combined Treatment Strategies
- First-line Therapy Development
Treatment Approaches
Primary focus includes investigating combination therapy regimens incorporating both targeted treatments and standard chemotherapy protocols, particularly with platinum-based agents and etoposide.
- Novel Drug Combinations
- Platinum-based Therapies
- Maintenance Treatment Strategies
Therapeutic Innovation
The investigator explores innovative immunotherapy approaches in lung cancer treatment, including evaluation of fixed-dose combinations and comparative effectiveness of different therapeutic regimens.
- Immunotherapy Development
- Treatment Optimization
- Survival Outcomes Research
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.